Skip to content

Oncology SupportOncology Support

Cancer treatment includes chemotherapy, hormone therapy and targeted therapy, adjusted to the type and stage of cancer involved. A few medicines here instead manage nausea, vomiting or other treatment effects.

Synthroid

Levothyroxine

25mcg · 50mcg · 75mcg · 100mcg · 125mcg · 150mcg · 200mcg

Designed to support metabolic systems to manage thyroid hormone deficiency and alleviate systemic lethargy.

From$0.13/ tabletView

Levothroid

Levothyroxine

25mcg · 50mcg · 75mcg · 100mcg · 112mcg · 125mcg · 200mcg

Formulated to alleviate hormone deficiencies to support baseline metabolic activity and target systemic lethargy.

From$0.24/ tabletView

Methotrexate Tablets

Methotrexate

2.5mg · 5mg · 7.5mg · 10mg

Utilised to manage rapid cell division to alleviate joint inflammation and support disease suppression.

From$0.41/ tabletView

Zofran

Ondansetron

4mg · 8mg

Developed to mitigate severe treatment-induced emesis to support nutritional intake during clinical therapies.

From$0.56/ tabletView

Nolvadex

Tamoxifen

10mg · 20mg

Designed to support estrogen receptor blockade to manage breast tumours and alleviate cellular tumour progression.

From$0.67/ tabletView

Zyloprim

Allopurinol

100mg · 300mg

Designed to support uric acid reduction to manage gout flares and alleviate tumour lysis metabolic complications.

From$0.57/ tabletView

Efudex

Fluorouracil

5%

Intended to relieve abnormal skin growth to support normal dermal healing and target precancerous epidermal tissues.

From$36.40/ tubeView

Evista

Raloxifene

60mg

Developed to mitigate postmenopausal bone density loss to support skeletal matrix strength and target breast tissue safety.

From$0.80/ tabletView

Tamoxifen Tablets

Tamoxifen

20mg

Formulated to alleviate estrogen-responsive tumour growth to support breast cancer remission and target cancer cells.

From$1.00/ tabletView

Altraz

Anastrozole

1mg

Designed to support hormone balance to manage neoplastic cell growth and alleviate tumour development risk.

From$3.92/ tabletView

Aromasin

Exemestane

25mg

Utilised to manage hormone responsive tumours to alleviate growth pathways and support endocrine maintenance protocols.

From$3.56/ tabletView

Casodex

Bicalutamide

50mg

Formulated to alleviate androgenic stimulation to support therapeutic oncology goals and target tumour progression.

From$8.13/ tabletView

Gleevec

Imatinib

400mg

Designed to support neoplastic cellular control to manage myeloid leukaemia and alleviate tumour tissue progression.

From$10.63/ tabletView

Cytoxan

Cyclophosphamide

50mg

Indicated to address malignant cellular proliferation to alleviate tumour development and support oncological disease control.

From$1.76/ tabletView

Zocitab

Capecitabine

500mg

Formulated to alleviate neoplastic cellular growth to support cancer remission and target tumour cell proliferation.

From$13.62/ tabletView

Hydrea

Hydroxycarbamide

500mg

Intended to relieve abnormal cellular proliferation to support clinical remission and target vascular sickle pain crises.

From$2.12/ tabletView

Purinethol

Mercaptopurine

50mg

Utilised to manage rapid lymphatic division to alleviate leukaemic cells and support therapeutic remission.

From$0.70/ tabletView

Eulexin

Flutamide

250mg

Indicated to address prostatic cellular proliferation to relieve tumour development and support oncological wellness.

From$2.29/ capsuleView

Alkeran

Melphalan

2mg

Indicated to address neoplastic cells to alleviate tumour burden and support systemic therapeutic protocols.

From$4.56/ tabletView

Leukeran

Chlorambucil

2mg

Designed to support neoplastic disease management to manage lymphocytic levels and alleviate tumour replication.

From$5.01/ tabletView

Kytril

Granisetron

1mg · 2mg

Intended to relieve severe treatment-induced emesis to support nutritional intake during clinical oncology therapies.

From$3.22/ tabletView

Thalix

Thalidomide

50mg

Intended to relieve multiple myeloma proliferation to support clinical remission and target neoplastic pathways.

From$2.98/ capsuleView

Nexavar

Sorafenib

200mg

Intended to relieve tumour tissue growth to support oncological cellular management and target intracellular signaling.

From$5.24/ tabletView

Sprycel

Dasatinib

50mg

Developed to mitigate malignant cell growth to support haematological safety and target tyrosine kinase activity.

From$129.00/ bottleView

Afinitor

Everolimus

5mg

Developed to target cancer cells to support tumour growth suppression.

From$43.64/ tabletView

Ibrutinib Capsules

Ibrutinib

140mg

Treats certain blood cancers by blocking Bruton's tyrosine kinase, a protein essential for b-cell cancer cell survival and proliferation, resulting to reduced tumour burden.

From$23.83/ capsuleView

Kisqali

Ribociclib

200mg

Treats hormone receptor-positive, HER2-negative breast cancer by inhibiting cyclin-dependent kinases 4 and 6, thereby halting cancer cell division and slowing tumour growth.

From$93.60/ tabletView

Lenalidomide Capsules

Lenalidomide

10mg

Treats multiple myeloma, myelodysplastic syndromes and certain lymphomas by modulating the immune system and directly targeting tumour cells, resulting in reduced cancer cell proliferation.

From$20.03/ capsuleView

Pomalyst

Pomalidomide

4mg

Treats relapsed and refractory multiple myeloma by modulating the immune system and directly targeting tumour cells through cereblon binding, producing anti-proliferative, anti-angiogenic and immunomodulatory effects.

From$63.90/ capsuleView

Ribociclib Tablets

Ribociclib

200mg

Treats hormone receptor-positive HER2-negative breast cancer by inhibiting cyclin-dependent kinases 4 and 6 to halt cancer cell division and slow tumour growth.

From$20.87/ tabletView

Tarceva

Erlotinib

100mg

Blocks epidermal growth factor receptor tyrosine kinase to stop cancer cells from growing and spreading in non-small cell lung cancer and pancreatic cancer.

From$16.27/ tabletView

Key points

  • Types of Cancer Treatment lists chemotherapy, hormone therapy, immunotherapy and targeted therapy among the main approaches, often used in combination.
  • Targeted Therapy for Cancer explains that these medicines target the proteins that control how cancer cells grow, divide and spread.
  • Testing a tumour for a specific target, called biomarker testing, often guides which targeted therapy is used.

Medicines for specific cancers

Tarceva contains erlotinib for non-small cell lung cancer, and with gemcitabine, for pancreatic cancer. Gleevec contains imatinib for chronic myeloid leukaemia and gastrointestinal stromal tumours. Sprycel contains dasatinib for chronic myeloid leukaemia and acute lymphoblastic leukaemia, and Ibrutinib Capsules treats chronic lymphocytic leukaemia, mantle cell lymphoma and Waldenström’s macroglobulinaemia. Afinitor contains everolimus for renal cell carcinoma, breast cancer and neuroendocrine tumours, and Nexavar contains sorafenib for liver, kidney and thyroid cancers. Kisqali and Ribociclib Tablets both contain ribociclib for hormone receptor-positive, HER2-negative breast cancer. Thalix, Lenalidomide Capsules and Pomalyst are related medicines for multiple myeloma, and Alkeran contains melphalan for multiple myeloma and ovarian carcinoma.

Hormone-blocking medicines for breast and prostate cancer

Tamoxifen Tablets, Nolvadex, Altraz and Aromasin block hormone activity in breast cancer, and Casodex and Eulexin do the same for prostate cancer. Evista contains raloxifene and is used to reduce breast cancer risk and prevent osteoporosis, rather than to treat existing cancer.

Further cancer medicines and supportive care

Leukeran treats chronic lymphocytic leukaemia and Hodgkin’s lymphoma, and Purinethol treats acute lymphocytic leukaemia. Hydrea treats chronic myeloid leukaemia, head and neck cancer and sickle cell anaemia. Cytoxan treats lymphomas and multiple myeloma. Zocitab contains capecitabine for metastatic breast cancer and for colorectal cancer, and Efudex is a topical medicine for actinic keratosis and superficial basal cell carcinoma. Zofran and Kytril manage chemotherapy or radiotherapy related nausea and vomiting, and Zyloprim manages high uric acid linked to cancer treatment.

Medicines here that do not treat cancer

Synthroid and Levothroid are thyroid hormone replacement medicines for an underactive thyroid. Low Dose Naltrexone Capsules treats fibromyalgia and multiple sclerosis related fatigue, and Fenbendazole Capsules treats helminthiasis, a parasitic worm infection.

Further reading